BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 13626647)

  • 1. AlphaB-crystallin-reactive T cells from knockout mice are not encephalitogenic.
    Wang C; Chou YK; Rich CM; Link JM; Afentoulis ME; van Noort JM; Wawrousek EF; Offner H; Vandenbark AA
    J Neuroimmunol; 2006 Jul; 176(1-2):51-62. PubMed ID: 16844233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
    Rich C; Link JM; Zamora A; Jacobsen H; Meza-Romero R; Offner H; Jones R; Burrows GG; Fugger L; Vandenbark AA
    Eur J Immunol; 2004 May; 34(5):1251-61. PubMed ID: 15114658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential numbers of foci of lymphocytes within the brains of Lewis rats exposed to weak complex nocturnal magnetic fields during development of experimental allergic encephalomyelitis.
    Persinger MA
    Int J Neurosci; 2009; 119(2):166-84. PubMed ID: 19125372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of immunoglobulins on morphological structure of the brain occipital part in experimental allergic encephalomyelitis].
    Mel'nyk VO
    Fiziol Zh (1994); 2006; 52(1):78-81. PubMed ID: 16553301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious leukoencephalitis. A critical comparison of certain experimental and naturally-occurring viral leukoencephalitides with experimental allergic encephalomyelitis.
    WAKSMAN BH; ADAMS RD
    J Neuropathol Exp Neurol; 1962 Oct; 21():491-518. PubMed ID: 13998401
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of Nigella sativa oil against experimental allergic encephalomyelitis via nitric oxide and other oxidative stress parameters.
    Ozugurlu F; Sahin S; Idiz N; Akyol O; Ilhan A; Yigitoglu R; Isik B
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):337-42. PubMed ID: 16191402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental allergic encephalomyelitis. Inhibition of clinical signs and paradoxical enhancement of lesions in second attacks.
    Levine S; Sowinski R
    Am J Pathol; 1980 Nov; 101(2):375-86. PubMed ID: 7435544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.
    Dimitrijević M; Rauski A; Radojević K; Kosec D; Stanojević S; Pilipović I; Leposavić G
    Eur J Pharmacol; 2007 Dec; 577(1-3):170-82. PubMed ID: 17854797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibiton of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99].
    Sun B; Yang S; Peng HS; Qiao H; Cao JY; Jin LH; Li HL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):106-9. PubMed ID: 17286899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis.
    Pettersson A; Ciumas C; Chirsky V; Link H; Huang YM; Xiao BG
    J Neuroimmunol; 2004 Nov; 156(1-2):58-65. PubMed ID: 15465596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
    Aroeira LS
    Clin Immunol; 2006 Jun; 119(3):252-60. PubMed ID: 16503420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of natural killer (NK) cell regulatory role in experimental autoimmune encephalomyelitis.
    Xu W; Fazekas G; Hara H; Tabira T
    J Neuroimmunol; 2005 Jun; 163(1-2):24-30. PubMed ID: 15885305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of acquired resistance to experimental allergic encephalomyelitis and of the development of the encephalitogenic brain-substance during ontogeny.
    SVET-MOLDAVSKAYA IA; SVET-MOLDAVSKY GI
    Acta Virol; 1959 Jan; 3(1):1-8. PubMed ID: 13626647
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.